tiprankstipranks
Trending News
More News >

G1 Therapeutics downgraded to Market Perform from Outperform at Raymond James

Raymond James downgraded G1 Therapeutics to Market Perform from Outperform after the company agreed to be acquired by Pharmacosmos for $7.15 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue